Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ocugen Inc OCGN

Healthcare Biotechnology
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. Its technology pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, and Inhaled Mucosal... see more

Bullboard (NDAQ:OCGN)

View:
1 2 3 4 5 Next
User Avatar Image
(3)
•••
  • Richardson35X
Post by Richardson35on Apr 13, 2023 3:21am

Kevin Harrington Discusses FSD Pharma

I believe this new product will aid society in reducing the ...more  
446
User Avatar Image
(3)
•••
  • Richardson35X
User Avatar Image
(3)
•••
  • Richardson35X
Post by Richardson35on Apr 30, 2022 2:53am

Lucid-MS for Multiple Sclerosis Treatment

277
User Avatar Image
(3)
•••
  • Richardson35X
Post by Richardson35on Apr 15, 2022 9:02am

FSD Pharma Inc: Lucid MS Video

FSD Pharma is delighted to announce pre-clinical findings ...more  
156
User Avatar Image
(3)
•••
  • Richardson35X
Post by Richardson35on Apr 09, 2022 1:32am

FSD: Cancellation of Certain Shares Issued to Former CEO

FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari   TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ...more  
136
User Avatar Image
(3)
•••
  • Richardson35X
Post by Richardson35on Apr 07, 2022 11:50am

FSD Pharma Issues Corporate Updates

FSD Pharma Issues Corporate Updates TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to ...more  
119
User Avatar Image
(3)
•••
  • Richardson35X
Post by Richardson35on Apr 06, 2022 1:08am

iMining: First Hospital Foundation in Decentraland Metaverse

iMining Enters into Agreement for the First-Ever Hospital Foundation to Be Launched in the Decentraland Metaverse   Vancouver, British Columbia--(Newsfile Corp.) - iMining Technologies Inc ...more  
151
User Avatar Image
(3)
•••
  • Richardson35X
Post by Richardson35on Feb 04, 2022 10:16am

FSD Pharma Inc: Lucid MS Video

FSD Pharma is pleased to share pre-clinical data demonstrating the effectiveness of its lead drug candidate, Lucid-MS, in treating Multiple Sclerosis. The unique potential therapeutic value of Lucid ...more  
142
User Avatar Image
(3)
•••
  • Richardson35X
Post by Richardson35on Dec 31, 2021 10:02pm

FSD Pharma Announces Share Repurchase Program

FSD Pharma Announces Share Repurchase Program   TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding ...more  
195
1 2 3 4 5 Next
Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities